Trial intelligence / Profile preview

CORTERAS: Corticosteroids for Early Recovery After Major Surgery in Elderly Patients

NCT05220319Phase 4Completed

Sponsor
Ziekenhuis Oost-Limburg
Start
Feb 2022
Primary completion
Sep 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial in muscle weakness and Systemic Inflammatory Response Syndrome (SIRS) comparing Placebo with Methylprednisolone (2 arms). Primary endpoint: Post operative muscle weakness. Started Feb 2022; status: completed.

02

Drugs

methylprednisolone injection
03

Conditions

muscle weaknessSystemic Inflammatory Response Syndrome (SIRS)

Beyond the preview

Go deeper on NCT05220319.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05220319.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call